- Home
- PRHI vs CODX Comparison
PRHI vs CODX Comparison
Compare PRHI & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRHI
- CODX
- Stock Information
- Founded
- PRHI 2009
- CODX 2013
- Country
- PRHI United States
- CODX United States
- Employees
- PRHI N/A
- CODX N/A
- Industry
- PRHI Property-Casualty Insurers
- CODX Medical/Dental Instruments
- Sector
- PRHI Finance
- CODX Health Care
- Exchange
- PRHI Nasdaq
- CODX Nasdaq
- Market Cap
- PRHI 17.5M
- CODX 15.6M
- IPO Year
- PRHI N/A
- CODX 2017
- Fundamental
- Price
- PRHI $0.91
- CODX $0.33
- Analyst Decision
- PRHI
- CODX Buy
- Analyst Count
- PRHI 0
- CODX 2
- Target Price
- PRHI N/A
- CODX $3.00
- AVG Volume (30 Days)
- PRHI 31.3K
- CODX 6.8M
- Earning Date
- PRHI 11-12-2025
- CODX 11-13-2025
- Dividend Yield
- PRHI N/A
- CODX N/A
- EPS Growth
- PRHI N/A
- CODX N/A
- EPS
- PRHI N/A
- CODX N/A
- Revenue
- PRHI $44,664,000.00
- CODX $507,892.00
- Revenue This Year
- PRHI $25.91
- CODX N/A
- Revenue Next Year
- PRHI N/A
- CODX $31.58
- P/E Ratio
- PRHI N/A
- CODX N/A
- Revenue Growth
- PRHI N/A
- CODX N/A
- 52 Week Low
- PRHI $0.42
- CODX $0.23
- 52 Week High
- PRHI $2.83
- CODX $1.55
- Technical
- Relative Strength Index (RSI)
- PRHI N/A
- CODX 45.81
- Support Level
- PRHI N/A
- CODX $0.31
- Resistance Level
- PRHI N/A
- CODX $0.38
- Average True Range (ATR)
- PRHI 0.00
- CODX 0.04
- MACD
- PRHI 0.00
- CODX -0.01
- Stochastic Oscillator
- PRHI 0.00
- CODX 16.76
About PRHI Presurance Holdings Inc. Common Stock
Presurance Holdings Inc Formerly Conifer Holdings Inc is an insurance holding company. The company markets and services the product offerings of the company through specialty personal insurance business lines. The company offers insurance products in Texas, Illinois, and Indiana for homeowners lines and Nevada and Michigan for other lines. The revenues of the company are derived from premiums earned from insurance operations.
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.